← Back to Clinical Trials
Recruiting NCT07561632

NCT07561632 Predictive Value of Early Peritraumatic Distress Screening for Childbirth-PTSD Following Unplanned Cesarean Delivery

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07561632
Status Recruiting
Phase —
Sponsor University of British Columbia
Condition Post Traumatic Stress Disorder
Study Type OBSERVATIONAL
Enrollment 420 participants
Start Date 2026-05-08
Primary Completion 2027-12

Eligibility & Interventions

Sex Female only
Min Age 19 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Postpartum Psychological Screening

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 420 participants in total. It began in 2026-05-08 with a primary completion date of 2027-12.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this observational study is to learn whether early postpartum screening tools can predict the development of childbirth-related post-traumatic stress symptoms in individuals who undergo unplanned cesarean delivery. The main questions it aims to answer are: * Do scores on the Peritraumatic Distress Inventory (PDI) collected 24-48 hours after delivery predict childbirth-related PTSD symptoms at 6 weeks postpartum? * Do scores on the City Birth Trauma Scale - Short Form (CityBiTS-SF) collected 24-48 hours after delivery predict childbirth-related PTSD symptoms at 6 weeks postpartum? Participants will: * Complete questionnaires within 24-48 hours after delivery, including the PDI, CityBiTS-SF, and Edinburgh Postnatal Depression Scale (EPDS). * Complete follow-up questionnaires at 6 weeks and 3 months postpartum, including measures of PTSD symptoms (PTSD Checklist for DSM-5, PCL-5) and depressive symptoms. Researchers will evaluate whether early screening scores are associated with later symptoms of childbirth-related PTSD and postpartum depression, and will assess the feasibility and acceptability of implementing routine inpatient screening for psychological birth trauma.

Eligibility Criteria

Inclusion Criteria: * Age ≥19 years * Underwent unplanned cesarean delivery * Able to provide informed consent * Able to read and understand English questionnaires Exclusion Criteria: * Fetal or neonatal demise * Unable to complete study questionnaires or provide informed consent

Contact & Investigator

Central Contact

Katherine Seligman, MD

✉ katie.seligman@cw.bc.ca

📞 604-875-2158

Frequently Asked Questions

Who can join the NCT07561632 clinical trial?

This trial is open to female participants only, aged 19 Years or older, studying Post Traumatic Stress Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07561632 currently recruiting?

Yes, NCT07561632 is actively recruiting participants. Contact the research team at katie.seligman@cw.bc.ca for enrollment information.

Where is the NCT07561632 trial being conducted?

This trial is being conducted at Vancouver, Canada.

Who is sponsoring the NCT07561632 clinical trial?

NCT07561632 is sponsored by University of British Columbia. The trial plans to enroll 420 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology